Sci Rep:三次犹豫模糊集的Dice测量和对良性前列腺增生症状的初步评估

2019-01-18 AlexYang MedSci原创

为了对一名患者进行良性前列腺增生(BPH)症状的初步评估,医生经常对患者进行临床询问,而患者的回应可能经常包括一些犹豫模糊和不确定的信息。然而,已经存在的BPH症状评估/诊断方法不能同时满足对患者犹豫和不确定信息的有效处理。更多的是,已经存在的评估方法可能会失去一些有用的信息(比如犹豫模糊信息),从而导致对患者病情的不合理或者不确定的评估/诊断。最近,有研究人员为了克服上述缺陷,首次引入了三次犹豫

为了对一名患者进行良性前列腺增生(BPH)症状的初步评估,医生经常对患者进行临床询问,而患者的回应可能经常包括一些犹豫模糊和不确定的信息。然而,已经存在的BPH症状评估/诊断方法不能同时满足对患者犹豫和不确定信息的有效处理。更多的是,已经存在的评估方法可能会失去一些有用的信息(比如犹豫模糊信息),从而导致对患者病情的不合理或者不确定的评估/诊断

最近,有研究人员为了克服上述缺陷,首次引入了三次犹豫模糊集(CHFS)的概念。该概念基于不确定/区间值模糊信息与犹豫不决的模糊信息相结合从而表达混合模糊信息。另外,研究人员还基于用于CHFS的犹豫模糊集最小公倍数(LCMC)基数的扩展方法提出了CHFSs之间的Dice测量。之后,对BPH症状的评估则通过CHFSs的Dice测量来对其进行初步评估。最后,研究人员将6名PBH患者的评估结果作为临床实际案例来表明CHFS中新开发评估方法的适用性和效果。

最后,研究人员通过与已经存在评估方法的比较,指出在研究的临床实际案例中,新开发的评估/诊断方法要比已经存在的评估/诊断方法要更优。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061268, encodeId=125b20612682c, content=<a href='/topic/show?id=87cb6808e71' target=_blank style='color:#2F92EE;'>#犹豫模糊集#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68087, encryptionId=87cb6808e71, topicName=犹豫模糊集)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Mon Mar 25 05:25:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654262, encodeId=0001165426221, content=<a href='/topic/show?id=59ae8665403' target=_blank style='color:#2F92EE;'>#良性前列腺增生症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86654, encryptionId=59ae8665403, topicName=良性前列腺增生症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7b24488510, createdName=zhishijing, createdTime=Mon Feb 25 21:25:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858932, encodeId=d54218589322d, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 16 11:25:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060449, encodeId=e8c02060449fa, content=<a href='/topic/show?id=06563221807' target=_blank style='color:#2F92EE;'>#初步评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32218, encryptionId=06563221807, topicName=初步评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Sun Oct 20 06:25:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358678, encodeId=e8b73586e811, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jan 20 06:43:24 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509693, encodeId=e7b5150969336, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Jan 20 03:25:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061268, encodeId=125b20612682c, content=<a href='/topic/show?id=87cb6808e71' target=_blank style='color:#2F92EE;'>#犹豫模糊集#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68087, encryptionId=87cb6808e71, topicName=犹豫模糊集)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Mon Mar 25 05:25:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654262, encodeId=0001165426221, content=<a href='/topic/show?id=59ae8665403' target=_blank style='color:#2F92EE;'>#良性前列腺增生症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86654, encryptionId=59ae8665403, topicName=良性前列腺增生症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7b24488510, createdName=zhishijing, createdTime=Mon Feb 25 21:25:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858932, encodeId=d54218589322d, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 16 11:25:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060449, encodeId=e8c02060449fa, content=<a href='/topic/show?id=06563221807' target=_blank style='color:#2F92EE;'>#初步评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32218, encryptionId=06563221807, topicName=初步评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Sun Oct 20 06:25:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358678, encodeId=e8b73586e811, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jan 20 06:43:24 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509693, encodeId=e7b5150969336, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Jan 20 03:25:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2061268, encodeId=125b20612682c, content=<a href='/topic/show?id=87cb6808e71' target=_blank style='color:#2F92EE;'>#犹豫模糊集#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68087, encryptionId=87cb6808e71, topicName=犹豫模糊集)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Mon Mar 25 05:25:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654262, encodeId=0001165426221, content=<a href='/topic/show?id=59ae8665403' target=_blank style='color:#2F92EE;'>#良性前列腺增生症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86654, encryptionId=59ae8665403, topicName=良性前列腺增生症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7b24488510, createdName=zhishijing, createdTime=Mon Feb 25 21:25:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858932, encodeId=d54218589322d, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 16 11:25:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060449, encodeId=e8c02060449fa, content=<a href='/topic/show?id=06563221807' target=_blank style='color:#2F92EE;'>#初步评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32218, encryptionId=06563221807, topicName=初步评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Sun Oct 20 06:25:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358678, encodeId=e8b73586e811, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jan 20 06:43:24 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509693, encodeId=e7b5150969336, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Jan 20 03:25:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
    2019-11-16 jeanqiuqiu
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061268, encodeId=125b20612682c, content=<a href='/topic/show?id=87cb6808e71' target=_blank style='color:#2F92EE;'>#犹豫模糊集#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68087, encryptionId=87cb6808e71, topicName=犹豫模糊集)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Mon Mar 25 05:25:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654262, encodeId=0001165426221, content=<a href='/topic/show?id=59ae8665403' target=_blank style='color:#2F92EE;'>#良性前列腺增生症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86654, encryptionId=59ae8665403, topicName=良性前列腺增生症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7b24488510, createdName=zhishijing, createdTime=Mon Feb 25 21:25:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858932, encodeId=d54218589322d, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 16 11:25:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060449, encodeId=e8c02060449fa, content=<a href='/topic/show?id=06563221807' target=_blank style='color:#2F92EE;'>#初步评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32218, encryptionId=06563221807, topicName=初步评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Sun Oct 20 06:25:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358678, encodeId=e8b73586e811, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jan 20 06:43:24 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509693, encodeId=e7b5150969336, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Jan 20 03:25:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2061268, encodeId=125b20612682c, content=<a href='/topic/show?id=87cb6808e71' target=_blank style='color:#2F92EE;'>#犹豫模糊集#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68087, encryptionId=87cb6808e71, topicName=犹豫模糊集)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Mon Mar 25 05:25:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654262, encodeId=0001165426221, content=<a href='/topic/show?id=59ae8665403' target=_blank style='color:#2F92EE;'>#良性前列腺增生症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86654, encryptionId=59ae8665403, topicName=良性前列腺增生症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7b24488510, createdName=zhishijing, createdTime=Mon Feb 25 21:25:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858932, encodeId=d54218589322d, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 16 11:25:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060449, encodeId=e8c02060449fa, content=<a href='/topic/show?id=06563221807' target=_blank style='color:#2F92EE;'>#初步评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32218, encryptionId=06563221807, topicName=初步评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Sun Oct 20 06:25:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358678, encodeId=e8b73586e811, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jan 20 06:43:24 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509693, encodeId=e7b5150969336, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Jan 20 03:25:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
    2019-01-20 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2061268, encodeId=125b20612682c, content=<a href='/topic/show?id=87cb6808e71' target=_blank style='color:#2F92EE;'>#犹豫模糊集#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68087, encryptionId=87cb6808e71, topicName=犹豫模糊集)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Mon Mar 25 05:25:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654262, encodeId=0001165426221, content=<a href='/topic/show?id=59ae8665403' target=_blank style='color:#2F92EE;'>#良性前列腺增生症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86654, encryptionId=59ae8665403, topicName=良性前列腺增生症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7b24488510, createdName=zhishijing, createdTime=Mon Feb 25 21:25:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858932, encodeId=d54218589322d, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 16 11:25:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060449, encodeId=e8c02060449fa, content=<a href='/topic/show?id=06563221807' target=_blank style='color:#2F92EE;'>#初步评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32218, encryptionId=06563221807, topicName=初步评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Sun Oct 20 06:25:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358678, encodeId=e8b73586e811, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jan 20 06:43:24 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509693, encodeId=e7b5150969336, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Jan 20 03:25:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]

相关资讯

Prostate Cancer P D:良性前列腺增生的对流射频水蒸汽热疗法研究

Rezūm 系统的对流射频水蒸汽热疗法是治疗良性前列腺增生(BPH)的一种相对比较新的治疗方法。最近,有研究人员在办公室里就一个外科医生的相关研究结果进行了呈现。在研究中,研究人员对该外科医生进行了Rezūm 系统的129名病人进行了回顾。所有的病人至少距离接受治疗时间为4个月。另外,研究人员对国际前列腺症状得分(IPSS)、最大流速(Qmax)、残余尿量、药物使用情况和副作用事件进行了调查,并在

读非那雄胺的诞生故事谈前列腺增生的治疗药物及慎用药物

非那雄胺片(商品名:保列治®)这个治疗男性前列腺增生(BPH)处方药,相信大家都不陌生,该药的诞生除了倾注了研发人员的大量心血外,还和一个美丽岛国偏远部落里的一个“变性”孩子的故事有关。

Phytother Res:百里醌对睾丸素诱导的良性前列腺增生具有抑制作用

最近,有研究人员阐释了在大鼠中,百里醌(TQ)对试验条件下诱导的良性前列腺增生(BPH)的发展具有可能的保护性作用。在试验中,18只成年雄性大鼠分为3个小组;阴性对照组(n=6)接受介质注射,另外两个组接受皮下睾丸素注射(3mg/kg)。再将接受睾丸素注射的大鼠随机分成BPH不处理组(n=6)和BPH+TQ处理组(n=6,5mg/kg口服14天)。研究人员还分析了组织学变化和转变生长因子-β1(T

Prostate Cancer P D:痛风患者良性前列腺增生风险研究

最近,有研究人员利用来自台湾地区健康研究数据库中的数据,在男性群体中评估了痛风和良性前列腺增生风险之间的相关性。研究包括了29269名患有痛风患者和29269名与之匹配的不患有痛风的患者的数据,时间在1997年到2010年之间。研究人员利用Cox风险比例模型评估了痛风与良性前列腺增生之间的相关性,并且还评估了痛风的年龄和痛风表型与良性前列腺增生的相关性。研究发现,患有痛风的患者的良性前列腺增生的发

Sci Rep:良性前列腺增生的下尿路症状负担

良性前列腺增生在老龄男性中是一种常见的非恶性肿瘤情况,但是该病的流行病学很少被鉴定分析。最近,有研究人员概括了和研究了良性前列腺增生的全球流行程度。研究人员系统的搜索了 PubMed、EMBASE和CENTRAL数据库中直到2016年7月31日的相关研究。研究人员搜集了那些描述良性前列腺增生的研究并且计算了累计估计的患病率估计。研究中共鉴定了31个来自25个国家的患病率估计。联合的患病率估计表明,

BMJ:前列腺增生继发下尿路症状临床治疗方法比较研究

研究认为,前列腺动脉栓塞与电切治疗前列腺增生继发下尿路症状的临床疗效差异不显著,但栓塞对患者前列腺功能改善的效果劣于电切治疗,不良事件更少